Headlines about Trupanion (NYSE:TRUP) have been trending somewhat positive on Saturday, Accern Sentiment Analysis reports. The research group ranks the sentiment of press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Trupanion earned a daily sentiment score of 0.12 on Accern’s scale. Accern also gave media stories about the financial services provider an impact score of 45.5078058946256 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Trupanion (NYSE:TRUP) opened at 22.10 on Friday. The firm’s 50-day moving average price is $22.86 and its 200 day moving average price is $18.38. The firm’s market capitalization is $662.89 million. Trupanion has a 1-year low of $13.71 and a 1-year high of $25.00.
Trupanion (NYSE:TRUP) last released its earnings results on Tuesday, August 1st. The financial services provider reported ($0.02) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.01. The firm had revenue of $58.30 million during the quarter, compared to the consensus estimate of $57.58 million. Trupanion had a negative return on equity of 13.24% and a negative net margin of 2.71%. The company’s revenue was up 27.3% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.03) EPS. On average, analysts predict that Trupanion will post ($0.10) EPS for the current year.
Several research analysts recently commented on the company. TheStreet raised Trupanion from a “d” rating to a “c-” rating in a research report on Monday, July 17th. Zacks Investment Research raised Trupanion from a “sell” rating to a “hold” rating in a research report on Tuesday, July 18th. Canaccord Genuity raised their target price on Trupanion from $28.00 to $29.00 and gave the stock a “buy” rating in a research report on Wednesday, August 2nd. BidaskClub cut Trupanion from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th. Finally, ValuEngine raised Trupanion from a “sell” rating to a “hold” rating in a research report on Friday, June 2nd. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $24.50.
In other news, insider Asher Bearman sold 10,900 shares of the company’s stock in a transaction on Monday, August 14th. The stock was sold at an average price of $22.83, for a total transaction of $248,847.00. Following the completion of the sale, the insider now directly owns 11,539 shares in the company, valued at approximately $263,435.37. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, COO Ian Moffat sold 8,552 shares of the company’s stock in a transaction on Friday, August 4th. The shares were sold at an average price of $23.20, for a total value of $198,406.40. Following the sale, the chief operating officer now owns 8,552 shares of the company’s stock, valued at $198,406.40. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 48,052 shares of company stock valued at $1,086,489.
About Trupanion
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
Receive News & Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related companies with MarketBeat.com's FREE daily email newsletter.
